← Open Payments lookup

THOMAS LAMBERT: Open Payments

NPI 1649222167 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,641 in 65 payments from 20 companies in 2025. Trend: 2023 $1,064 · 2024 $881 · 2025 $1,641

Food & beverage: $1,641
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation10$213
Amgen Inc.16$201
Abbott Laboratories3$165
Pacira Pharmaceuticals Incorporated1$122
PFIZER INC.5$117
Merck Sharp & Dohme LLC4$100
Alnylam Pharmaceuticals Inc.3$88
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)1$86
E.R. Squibb & Sons, L.L.C.3$78
BridgeBio Pharma, Inc.3$76

Products named: REPATHA, LEQVIO, AVEIR, Exparel, VYNDAQEL, AMVUTTRA, LifeVest, Attruby.

Industry payments across NV — which companies pay providers there.